You are here:Home-Chemical Inhibitors & Agonists-Proteasome/Ubiquitin-E3 Ubiquitin Ligase-PELI1-EGFR inhibitor S62
PELI1-EGFR inhibitor S62

Chemical Structure : PELI1-EGFR inhibitor S62

CAS No.:

PELI1-EGFR inhibitor S62

Catalog No.: PC-20113Not For Human Use, Lab Use Only.

PELI1-EGFR inhibitor S62 is a small molecule inhibitor of the interaction between PELI1 and EGFR, suppresses breast cancer metastasis.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    PELI1-EGFR inhibitor S62 is a small molecule inhibitor of the interaction between Pellino-1 (PELI1) and EGFR, suppresses breast cancer metastasis.
    PELI1-EGFR inhibitor S62 (5-10 uM) reduced both protein levels of PELI1 and EGFR in MDA-MB-231 cells, also decrease of the membrane EGFR.
    PELI1-EGFR inhibitor S62 did not block the phosphorylation of EGFR upon EGF stimulation.
    PELI1-EGFR inhibitor S62 reduced the tyrosine and threonine phosphorylation of PELI1 and K63-linked ubiquitination of EGFR.
    PELI1-EGFR inhibitor S62 inhibited the metastasis of MDA-MB-231 cells MDA-MB-231 cells-derived tumor nodules in lung after caudal vein injection.
    PELI1-EGFR inhibitor S62 is a disruptor of PELI1 and EGFR interaction but not binding to PELI1 or EGFR alone.
    Pellino-1 (PELI1) is an E3 ubiquitin ligase acting as a key regulator for the inflammation and autoimmunity via the ubiquitination of the substrate proteins, EGFR is positively correlated with PELI1 expression in breast cancers.

    Physicochemical Properties

    M.Wt 412.59
    Formula C24H32N2O2S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    4-((2-decanamidophenyl)thio)-N-methylbenzamide

    References

    1. Qi J, et al. Oncogenesis. 2023 Feb 25;12(1):9.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: